Quercetin

Quercetin

SCHEMBL4473370

O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.O=c1c(OP(=O)(O)O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.74
KMT2A Q03164 8/20 0.74
POLH Q9Y253 8/20 0.74
KDM4E B2RXH2 6/20 0.74
HSD17B10 Q99714 6/20 0.74
CYP1A2 P05177 6/20 0.74
RECQL P46063 5/20 0.74
CYP3A4 P08684 5/20 0.74
MAPT P10636 5/20 0.74
IPMK Q8NFU5 5/20 0.74
IP6K2 Q9UHH9 5/20 0.74
CYP1A1 P04798 5/20 0.74
CYP1B1 Q16678 5/20 0.74
POLB P06746 4/20 0.74
CYP2C9 P11712 4/20 0.74
ALOX15 P16050 4/20 0.74
HIF1A Q16665 4/20 0.74
APP P05067 4/20 0.74
AKR1B1 P15121 4/20 0.74
TDP1 Q9NUW8 4/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120010 0.96 POLH (0.72) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL30512465 0.89 MEN1 (0.90) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL4473368 0.89 MEN1 (0.90) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL1148195 0.89 MEN1 (0.90) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL4815328 0.87 MEN1 (0.97) MEN1KMT2APOLHKDM4EHSD17B10
SCHEMBL119670 0.87 POLH (0.73) MEN1KMT2APOLHKDM4EHSD17B10
SCHEMBL19469990 0.86 MEN1 (0.72) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL19723 0.86 MEN1 (1.00) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL118425 0.86 MEN1 (1.00) MEN1KMT2APOLHKDM4EHSD17B10
Quercetin SCHEMBL17629824 0.86 MEN1 (1.00) MEN1KMT2APOLHKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158007-A2 METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT LIMERICK BIOPHARMA, INC. (US) 2009-12-30 WO claimed